Prem S. Shah - Jan 1, 2022 Form 3 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Prem S. Shah
Stock symbol
CVS
Transactions as of
Jan 1, 2022
Transactions value $
$0
Form type
3
Date filed
1/10/2022, 04:13 PM
Next filing
Feb 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock 12K Jan 1, 2022 Direct
holding CVS Common Stock (restricted) 575 Jan 1, 2022 Direct F1
holding CVS Common Stock (restricted) 2.88K Jan 1, 2022 Direct F2
holding CVS Common Stock (restricted) 15.4K Jan 1, 2022 Direct F3
holding CVS Common Stock (restricted) 1.81K Jan 1, 2022 Direct F4
holding CVS Common Stock (restricted) 1.93K Jan 1, 2022 Direct F5
holding CVS Common Stock (restricted) 6.39K Jan 1, 2022 Direct F6
holding CVS Common Stock (restricted) 4.37K Jan 1, 2022 Direct F7
holding CVS Common Stock (restricted) 2.8K Jan 1, 2022 Direct F8
holding CVS Stock Unit (deferred) 5.63K Jan 1, 2022 Direct F9

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option Jan 1, 2022 Common Stock 5.87K $104.82 Direct F10
holding CVS Stock Option Jan 1, 2022 Common Stock 5.35K $102.26 Direct F11
holding CVS Stock Option Jan 1, 2022 Common Stock 1.69K $62.20 Direct F12
holding CVS Stock Option Jan 1, 2022 Common Stock 12.6K $54.19 Direct F13
holding CVS Stock Option Jan 1, 2022 Common Stock 34.3K $58.34 Direct F14
holding CVS Stock Option Jan 1, 2022 Common Stock 32.8K $74.30 Direct F15
holding CVS Stock Option Jan 1, 2022 Common Stock 26.6K $75.24 Direct F16
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of remaining Restricted Stock Units (RSUs) awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan (ICP). Restrictions lapse on 02/28/2022.
F2 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in two equal installments commencing on 04/01/2022.
F3 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in three equal installments commencing on 04/01/2022.
F4 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions lapse on 04/01/2022.
F5 Consists of remaining RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 ICP. Restrictions lapse in two equal installments commencing on 02/28/2022.
F6 Consists of RSUs awarded pursuant to Issuer's 2017 ICP. Restrictions on remaining RSUs lapse in four equal installments commencing on 04/01/2022.
F7 Consists of Matching RSUs awarded pursuant to Issuer's Partnership Equity Program, a sub-plan under its ICP, and dividend equivalents on the Matching RSUs. Restrictions lapse on the RSUs on 08/31/2023.
F8 Consists of RSUs awarded pursuant to Issuer's Performance-Based Restricted Stock Plan under its 2017 ICP. Restrictions lapse in three equal installments commencing on 02/26/2022.
F9 Consists of Stock Units awarded pursuant to Issuer's 2010 & 2017 Incentive Compensation Plans, the receipt of which the reporting person has elected to defer.
F10 Option becomes exercisable in four equal installments commencing 04/01/2017.
F11 Option becomes exercisable in four equal installments commencing 04/01/2016.
F12 Option becomes exercisable in four equal installments commencing 04/01/2019. Additional options from this award have been exercised.
F13 Option becomes exercisable in four equal installments commencing 04/01/2020. Additional options from this award have been exercised.
F14 Option becomes exercisable in four equal installments commencing 04/01/2021. Additional options from this award have been exercised.
F15 Option becomes exercisable in three equal installments commencing 04/01/2022.
F16 Option vests in three equal installments, on 8/31/2021, 8/31/2022 and 8/31/2023.